Globus Medical Reports First Quarter 2025 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Globus Medical (GMED) PT Lowered to $78 at Oppenheimer
May 9, 2025 10:21 AM EDTOppenheimer analyst Steven Lichtman lowered the price target on Globus Medical (NYSE: GMED) to $78.00 (from $90.00) while maintaining a Perform rating.
The analyst commented, "Globus Medical's 1Q25 sales of $598.1 (-0.8% constant currency) missed our/Street's ~$630.1/$626M estimates. Musculoskeletal was softer on several factors including timing... More
Globus Medical (GMED) Misses Q1 EPS by 7c, Offers Guidance
May 8, 2025 4:58 PM EDTGlobus Medical (NYSE: GMED) reported Q1 EPS of $0.68, $0.07 worse than the analyst estimate of $0.75. Revenue for the quarter came in at $598.1 million versus the consensus estimate of $631.09 million.
GUIDANCE:
Globus Medical sees FY2025 EPS of $3.00-$3.30, versus the consensus of... More
